Allarity Therapeutics, Inc. (ALLR)

Last Closing Price: 1.09 (2022-09-26)

Company Description

Allarity Therapeutics Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel oncology therapeutics together with drug-specific DRP(R) companion diagnostics for personalized cancer care. Allarity Therapeutics Inc. is based in Cambridge, MA U.S.A.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-26.65M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 0.65
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) --
Return on Assets (Trailing 12 Months) --
Current Ratio (Most Recent Fiscal Quarter) 1.02
Quick Ratio (Most Recent Fiscal Quarter) 1.02
Debt to Common Equity (Most Recent Fiscal Quarter) 0.05
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Quarter) $0.78
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Stock
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Common Shares Outstanding 10.26M
Free Float 9.76M
Market Capitalization $11.18M
Average Volume (Last 20 Days) 0.16M
Beta (Past 60 Months) --
Percentage Held By Insiders (Latest Annual Proxy Report) 4.86%
Percentage Held By Institutions (Latest 13F Reports) 2.38%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%